Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 7
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.
Krejci D, Opalka P, Krejci J, Zemanova M, Zemanova P, Kultan J, Fischer O, Skrickova J, Bratova M, Cernovska M, Hrnciarik M, Coupkova H, Hurdalkova K, Barinova M, Koubkova L, Dolezal D, Safanda M, Pesek M, Svaton M. Krejci D, et al. Among authors: hurdalkova k. Anticancer Res. 2021 May;41(5):2597-2603. doi: 10.21873/anticanres.15039. Anticancer Res. 2021. PMID: 33952489
Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.
Skrickova J, Pesek M, Opalka P, Koubkova L, Zemanova M, Hrnciarik M, Blazek J, Svaton M, Krejci J, Coupkova H, Dolezal D, Tuzova T, Holubec L, Mahadevia P, Sandstrom K, Kunovszki P, Barinova M, Hurdalkova K, Fischer O, Cernovska M, Bratova M. Skrickova J, et al. Among authors: hurdalkova k. Anticancer Res. 2021 Nov;41(11):5625-5634. doi: 10.21873/anticanres.15378. Anticancer Res. 2021. PMID: 34732435
Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.
Brat K, Bratova M, Skrickova J, Barinova M, Hurdalkova K, Pesek M, Havel L, Koubkova L, Hrnciarik M, Krejci J, Fischer O, Zemanova M, Coupkova H, Svaton M. Brat K, et al. Among authors: hurdalkova k. Thorac Cancer. 2020 Nov;11(11):3346-3356. doi: 10.1111/1759-7714.13679. Epub 2020 Oct 5. Thorac Cancer. 2020. PMID: 33016001 Free PMC article.
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer.
Svaton M, Zemanova M, Zemanova P, Kultan J, Fischer O, Skrickova J, Jakubikova L, Cernovska M, Hrnciarik M, Jirousek M, Krejci J, Krejci D, Bilek O, Blazek J, Hurdalkova K, Barinova M, Melichar B. Svaton M, et al. Among authors: hurdalkova k. Anticancer Res. 2020 Apr;40(4):2209-2217. doi: 10.21873/anticanres.14182. Anticancer Res. 2020. PMID: 32234916
11 results